MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 05-16-2026
DURECT Corporation Depreciation & Amortization 2011-2026 | DRRX
Annual Depreciation & Amortization DURECT Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84 K | 31 K | 119 K | 288 K | 297 K | 291 K | 254 K | 437 K | 416 K | 425 K | 601 K | 558 K | 964 K | 1.18 M | 2.25 M | 2.51 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.51 M | 31 K | 669 K |
Quarterly Depreciation & Amortization DURECT Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89 K | 69 K | - | - | 51 K | - | - | 44 K | - | 109 K | - | 34 K | - | 92 K | - | 30 K | - | 219 K | 139 K | 62 K | - | 224 K | 153 K | 82 K | - | 162 K | 221 K | 108 K | - | 333 K | 224 K | 112 K | - | 309 K | 206 K | 101 K | - | 342 K | 260 K | 144 K | - | 462 K | 310 K | 155 K | - | 381 K | 512 K | 258 K | - | 688 K | 429 K | 205 K | - | 735 K | 519 K | 284 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 735 K | 30 K | 233 K |
Depreciation & Amortization of other stocks in the Drug manufacturers industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
306 M | - | - | $ 28.9 M |  Irlanda |
 |
AcelRx Pharmaceuticals
ACRX
|
311 K | - | 7.5 % | $ 6.35 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
1.48 M | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
6.4 M | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
102 K | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
8.75 M | - | - | $ 142 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
4.15 M | $ 6.39 | 8.86 % | $ 94.9 M | USA |
 |
Cronos Group
CRON
|
14.2 M | $ 2.74 | -0.18 % | $ 1.05 B |  Canada |
 |
Athenex
ATNX
|
4.47 M | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
1.32 M | $ 33.13 | 0.38 % | $ 1.22 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
2.68 M | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
489 M | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
646 K | - | -39.89 % | $ 27.7 M | USA |
 |
Bausch Health Companies
BHC
|
1.21 B | $ 5.56 | 1.65 % | $ 2.06 B | Canada |
 |
Organogenesis Holdings
ORGO
|
15.3 M | $ 2.62 | -1.69 % | $ 332 M | USA |
 |
Pacira BioSciences
PCRX
|
78.8 M | $ 23.26 | -0.41 % | $ 1.08 B | USA |
 |
Canopy Growth Corporation
CGC
|
21.5 M | $ 1.08 | 3.84 % | $ 116 M | Canada |
 |
Solid Biosciences
SLDB
|
1.64 M | $ 6.91 | 4.31 % | $ 605 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
138 K | $ 1.12 | 1.36 % | $ 1.39 M | USA |
 |
Jupiter Wellness
JUPW
|
654 K | - | - | $ 33.6 M | USA |
 |
Tilray
TLRY
|
35.7 M | $ 5.46 | 3.22 % | $ 3.37 B | Canada |
 |
Lannett Company
LCI
|
34.3 M | - | 1.15 % | $ 7.11 M | USA |
 |
Evolus
EOLS
|
7.51 M | $ 6.07 | -0.33 % | $ 391 M | USA |
 |
Emergent BioSolutions
EBS
|
95.8 M | $ 8.93 | 5.68 % | $ 478 M | USA |
 |
Veru
VERU
|
152 K | $ 2.39 | 1.86 % | $ 35 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
3.04 M | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
30 M | $ 23.45 | 0.04 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
4.72 M | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
1.16 M | - | - | $ 1.42 B | USA |
 |
cbdMD
YCBD
|
361 K | $ 0.75 | -1.83 % | $ 3.02 M | USA |
 |
PetIQ
PETQ
|
44.5 M | - | 1.64 % | $ 400 M | USA |
 |
Relmada Therapeutics
RLMD
|
1.26 K | $ 6.95 | -1.35 % | $ 274 M | USA |
 |
Recro Pharma
REPH
|
8.22 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
402 K | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
580 K | $ 0.73 | -0.29 % | $ 36.5 M | USA |
 |
PLx Pharma
PLXP
|
116 K | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
2.8 B | $ 16.54 | -0.69 % | $ 19.4 B | USA |
 |
Zomedica Corp.
ZOM
|
2.06 M | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
219 K | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
2.19 M | - | - | $ 29.1 M | USA |
 |
Tricida
TCDA
|
442 K | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
1.5 M | $ 0.79 | 3.21 % | $ 3.39 M |  China |
 |
TherapeuticsMD
TXMD
|
384 K | $ 2.02 | -4.71 % | $ 23.4 M | USA |